1. Home
  2. ZD vs BEAM Comparison

ZD vs BEAM Comparison

Compare ZD & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZD
  • BEAM
  • Stock Information
  • Founded
  • ZD 1995
  • BEAM 2017
  • Country
  • ZD United States
  • BEAM United States
  • Employees
  • ZD N/A
  • BEAM N/A
  • Industry
  • ZD Advertising
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZD Consumer Discretionary
  • BEAM Health Care
  • Exchange
  • ZD Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • ZD 2.0B
  • BEAM 1.9B
  • IPO Year
  • ZD 1999
  • BEAM 2020
  • Fundamental
  • Price
  • ZD $56.65
  • BEAM $27.18
  • Analyst Decision
  • ZD Buy
  • BEAM Buy
  • Analyst Count
  • ZD 8
  • BEAM 11
  • Target Price
  • ZD $71.50
  • BEAM $45.90
  • AVG Volume (30 Days)
  • ZD 441.8K
  • BEAM 1.2M
  • Earning Date
  • ZD 11-07-2024
  • BEAM 11-05-2024
  • Dividend Yield
  • ZD N/A
  • BEAM N/A
  • EPS Growth
  • ZD 41.53
  • BEAM N/A
  • EPS
  • ZD 1.38
  • BEAM N/A
  • Revenue
  • ZD $1,378,750,000.00
  • BEAM $349,643,000.00
  • Revenue This Year
  • ZD $7.04
  • BEAM N/A
  • Revenue Next Year
  • ZD $6.10
  • BEAM $9.04
  • P/E Ratio
  • ZD $41.17
  • BEAM N/A
  • Revenue Growth
  • ZD 0.58
  • BEAM 328.73
  • 52 Week Low
  • ZD $37.76
  • BEAM $18.85
  • 52 Week High
  • ZD $70.90
  • BEAM $49.50
  • Technical
  • Relative Strength Index (RSI)
  • ZD 77.70
  • BEAM 60.47
  • Support Level
  • ZD $48.01
  • BEAM $21.46
  • Resistance Level
  • ZD $51.03
  • BEAM $27.30
  • Average True Range (ATR)
  • ZD 1.58
  • BEAM 1.28
  • MACD
  • ZD 0.85
  • BEAM 0.45
  • Stochastic Oscillator
  • ZD 85.90
  • BEAM 80.54

About ZD Ziff Davis Inc.

Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

Share on Social Networks: